相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Erythropoietin attenuates high glucose-induced oxidative stress and inhibition of osteogenic differentiation in periodontal ligament stem cell (PDLSCs)
De-Hua Zheng et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2019)
Norepinephrine protects against apoptosis of mesenchymal stem cells induced by high glucose
Yanan Kong et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Myocyte enhancer factor 2A delays vascular endothelial cell senescence by activating the PI3K/p-Akt/SIRT1 pathway
Benrong Liu et al.
AGING-US (2019)
Effect of Rosmarinic Acid and Sinapic Acid on Oxidative Stress Parameters in the Cardiac Tissue and Serum of Type 2 Diabetic Female Rats
Maria Zych et al.
ANTIOXIDANTS (2019)
Diabetic Cardiomyopathy Modelling Using Induced Pluripotent Stem Cell Derived Cardiomyocytes: Recent Advances and Emerging Models
Cecilia Graneli et al.
STEM CELL REVIEWS AND REPORTS (2019)
Resveratrol alleviates chemotherapy-induced oogonial stem cell apoptosis and ovarian aging in mice
Meng Wu et al.
AGING-US (2019)
Hyperglycemia inhibits osteoblastogenesis of rat bone marrow stromal cells via activation of the Notch2 signaling pathway
Kuo-Chin Huang et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2019)
Resveratrol improves osteogenic differentiation of senescent bone mesenchymal stem cells through inhibiting endogenous reactive oxygen species production via AMPK activation
Ting Zhou et al.
REDOX REPORT (2019)
Global aetiology and epidemiology of type 2 diabetes mellitus and its complications
Yan Zheng et al.
NATURE REVIEWS ENDOCRINOLOGY (2018)
Chlorogenic Acid Protects Against oxLDL-Induced Oxidative Damage and Mitochondrial Dysfunction by Modulating SIRT1 in Endothelial Cells
Kun-Ling Tsai et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2018)
Addressing Stem Cell Therapeutic Approaches in Pathobiology of Diabetes and Its Complications
Bou-Yue Peng et al.
JOURNAL OF DIABETES RESEARCH (2018)
Resveratrol Enhances Self-Renewal of Mouse Embryonic Stem Cells
Na Li et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2017)
SIRT1 Activation by Resveratrol Alleviates Cardiac Dysfunction via Mitochondrial Regulation in Diabetic Cardiomyopathy Mice
Sai Ma et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2017)
A comprehensive review of the health perspectives of resveratrol
Abdur Rauf et al.
FOOD & FUNCTION (2017)
Functional Foods and Lifestyle Approaches for Diabetes Prevention and Management
Ahmad Alkhatib et al.
NUTRIENTS (2017)
Evaluation of current trends and recent development in insulin therapy for management of diabetes mellitus
Muhammad Sarfraz Nawaz et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2017)
The essential role of exercise in the management of type 2 diabetes
John P. Kirwan et al.
CLEVELAND CLINIC JOURNAL OF MEDICINE (2017)
Paracrine effect of CXCR4-overexpressing mesenchymal stem cells on ischemic heart injury
Shi-Zheng Wu et al.
CELL BIOCHEMISTRY AND FUNCTION (2017)
Stem cells and diabetic cardiomyopathy: from pathology to therapy
Mingfei Liu et al.
HEART FAILURE REVIEWS (2016)
Diabetic Cardiomyopathy: Does the Type of Diabetes Matter?
Maximilian E. Hoelscher et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Diabetes, Nutrition, and Exercise
Ahmed H. Abdelhafiz et al.
CLINICS IN LIVER DISEASE (2015)
Effects of Resveratrol and SIRT1 on PGC-1α Activity and Mitochondrial Biogenesis: A Reevaluation
Kazuhiko Higashida et al.
PLOS BIOLOGY (2013)
Diabetes triggers a PARP1 mediated death pathway in the heart through participation of FoxO1
Prasanth Puthanveetil et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2012)
Reduced MMP-2 activity contributes to cardiac fibrosis in experimental diabetic cardiomyopathy
Sophie Van Linthout et al.
BASIC RESEARCH IN CARDIOLOGY (2008)
Contributions of inflammation and cardiac matrix metalloproteinase activity to cardiac failure in diabetic cardiomyopathy -: The role of angiotensin type 1 receptor antagonism
Dirk Westermann et al.
DIABETES (2007)
Oxidative stress-dependent impairment of cardiac-specific transcription factors in experimental diabetes
Manuela Aragno et al.
ENDOCRINOLOGY (2006)
IGF-1 overexpression inhibits the development of diabetic cardiomyopathy and angiotensin II-mediated oxidative stress
J Kajstura et al.
DIABETES (2001)
分享论文
